"The overall goal is to save as many lives as possible, and with that we are not valuing any life over another." "We're trying to focus on those individuals who are most likely to develop severe illness or death, and to most likely be exposed to the virus," said Gabriel Lázaro-Muñoz, who teaches medical ethics and health policy at the Baylor College of Medicine in Houston. The situation highlights a serious ethical issue: determining who is entitled to a vaccine at a time of scarce availability and who is responsible for enforcing eligibility rules.Įxperts say an appropriate system for vaccine distribution focuses on first targeting those most at risk for serious consequences from COVID-19. One Medical's shortcomings take place amid broader anecdotal evidence that suggests patients of various health care providers throughout the country are skipping the line due in part to loose enforcement. The company went public with an IPO in January 2020, with a valuation in the billions. One Medical brands itself a high-end health care provider serving a relatively affluent clientele that pays a $199 fee annually to receive easy online access to appointments, telemedicine and access to a streamlined, tech-focused medical experience. Other regulators have also received complaints or stopped providing the vaccine. The Washington State Department of Health, citing a complaint it received this month, told NPR it had halted COVID-19 vaccine distribution to the company. The problems have occurred in numerous company locations across several states.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |